Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
about
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimenA randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adultsSynthetic DNA vaccine strategies against persistent viral infectionsCharacterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profilingRecombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus MacaquesSafety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West AfricaPartially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responsesHuman immunodeficiency virus vaccine trialsA human multi-epitope recombinant vaccinia virus as a universal T cell vaccine candidate against influenza virusDNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsEnhanced cellular immunity in macaques following a novel peptide immunotherapy.Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virionsComparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIVDifferential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunityImpairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeysReduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccinationProtection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectorsInduction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virusNovel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaquesMemory CD8+ T cells in HIV infectionEnhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraImmune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infectionProtective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimenThe dynamics of the cellular immune response to HIV infection: implications for vaccinationIdentification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicityMultispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing GagCytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesA combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene.
P2860
Q21089693-2A29C332-4656-445C-B297-5F5B1502B654Q24804936-7ACAB453-E6C3-4EF2-BA1B-E935504A857AQ27016078-F80413FA-EF48-4162-9B18-634454D50A99Q27320870-B82C5E5C-7FC1-4F00-A7EC-49CAE63650BBQ27491052-9D556F8B-61C3-4EC4-A7EE-C66E5AAAC0E8Q28473318-32E0FD8C-0A1B-491E-8283-C12FE9CD71A3Q28742762-DD58C41A-6D63-4848-92DA-74EC259D6C2AQ28749120-84DC056B-56AF-4DB2-9139-C8EBD855B759Q30424366-2FE122BC-0039-4BFB-B0DA-06C56CD824B3Q31037728-76AB4676-48E2-4A56-8B08-24B2749B1ACAQ33268303-1958EA6A-A0EE-4BD4-8FCE-8E7CD17BF690Q33303660-55BD7D10-5F62-4752-8A10-98DD8B4FAD18Q33737787-0E119D12-93ED-4792-BA5F-A217723FA038Q33743852-A2F90F49-3C60-424B-9B37-EF97DD49BB53Q33787271-1B70F28F-99E3-4BF3-B4A1-5DF130B106A7Q33800033-721429F4-6580-458E-B269-E013BF98B131Q33805975-60AFD60B-62D4-4DEC-AC7A-9307A05AC4C6Q33806715-EC7AFA7E-2560-4D5E-AEA0-41800B185353Q33834585-375E39E7-556A-4214-A127-676F99781F34Q33835440-0A08485F-4087-4877-8074-01654F51F83DQ33846454-A1ACF6A5-4DEF-4DD7-89AC-62B87C254187Q33849823-7711E6D7-1DA1-4821-8A0E-16810B2DBE57Q33850904-D421F593-C0A3-46EF-BDC0-E268A17D305FQ33851802-153ECF95-C65C-4DCF-B7F1-9086D064A326Q33852720-E1974BF4-720A-4C52-AE54-80F1517A1367Q33874561-CCAD4AF1-3EC1-4BEF-9B8C-1C2393D3BE50Q33877458-7B616E5E-85B8-4E37-9569-037CFFE2FD89Q33905214-91DD9F4C-1425-41E5-855E-8C7D6AEE310EQ33935092-BAA2AA8D-D50F-4A1C-9D86-FB631321CFCFQ34111806-D40D8224-E0E6-4F0A-950F-27E540FB46E4Q34119135-16E04C3E-E12E-4156-A424-22AD4DE2C11CQ34142869-FDAA6564-273F-479E-A22D-6C6C6E61778FQ34143929-3988EB4D-61E7-4A2F-BEF2-6CB7F8502CAEQ34186587-7EF6A43A-7CEC-4E6B-AF89-15A919D1FF10Q34226966-FAE0D773-8C31-4CAA-9C78-9D6BBF9351B8Q34227778-0E18145C-AD76-4825-B1C1-610896E5BFA0Q34228487-E8D47C81-C40C-4936-9AE0-A366157CF9E4Q34228494-6E19ABBD-D38D-4C44-84D4-C15174DAC6A7Q34228507-B11FB3B3-7B6C-44F7-8196-AA761716D6AEQ34326532-77C17D6D-BA14-40FB-BBA9-AF0DB295BA3B
P2860
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effective induction of simian ...... kara boost vaccination regimen
@ast
Effective induction of simian ...... kara boost vaccination regimen
@en
type
label
Effective induction of simian ...... kara boost vaccination regimen
@ast
Effective induction of simian ...... kara boost vaccination regimen
@en
prefLabel
Effective induction of simian ...... kara boost vaccination regimen
@ast
Effective induction of simian ...... kara boost vaccination regimen
@en
P2093
P2860
P1433
P1476
Effective induction of simian ...... kara boost vaccination regimen
@en
P2093
A J McMichael
D I Watkins
J E Boyson
M P Cranage
R V Samuel
S A Sharpe
T J Blanchard
P2860
P304
P577
1999-09-01T00:00:00Z